INFLUENCE OF TOTAL NUCLEATED CELL DOSE FROM MARROW HARVESTS ON OUTCOME IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA UNDERGOING AUTOLOGOUS TRANSPLANTATION
T. Demirer et al., INFLUENCE OF TOTAL NUCLEATED CELL DOSE FROM MARROW HARVESTS ON OUTCOME IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA UNDERGOING AUTOLOGOUS TRANSPLANTATION, Bone marrow transplantation, 15(6), 1995, pp. 907-913
This retrospective study was conducted to determine whether the total
number of nucleated cells (TNC)/kg collected at marrow harvest was ass
ociated with out-come in 151 patients with acute myelogenous leukemia
(AML) who received an autologous purged (n = 67) or non-purged (n = 84
) marrow transplant, At the time of transplant 33 patients were in fir
st complete remission (CR), 47 in second CR, 54 in first relapse and 1
7 beyond second CR, Ninety patients received busulfan (BU) 16 mg/kg an
d cyclophosphamide (CY) 120 or 200 mg/kg, 51 patients received CY 120
mg/kg and total body irradiation (TBI) 12-15.75 Gy and 10 patients rec
eived BU 8 mg/kg, CY 60 mg/kg and TBI 12 Gy as conditioning regimens,
Patients whose marrow harvest yielded <2 x 10(8) TNC/kg did not underg
o purging with 4-hydroperoxycyclophosphamide (4HC). This group of pati
ents (n = 28) had a 100 day mortality of 50% and only 54% achieved a g
ranulocyte levels of >0.5 x 10(9)/l and 29% achieved platelet transfus
ion independence, Patients whose marrow harvest yielded 2-4 x 10(8) TN
C/kg and did not undergo marrow purging had a 20% mortality by day 100
, 91% recovered granulocytes to >0.5 x 10(9)/l and 61% became platelet
independent, Patients whose marrow harvest yielded 2-4 x 10(8) TNC/kg
and underwent marrow purging with 4HC had a 50% mortality by day 100
and 58% achieved a granulocyte levels of >0.5 x 10(9)/l and 42% became
platelet transfusion independent. Patients whose marrow yielded >4 x
10(8) TNC/kg and underwent marrow purging with 4HC had a 35% mortality
by day 100 and 79% achieved a granulocyte levels of >0.5 x 10(9)/l an
d 51% became platelet independent. In a multivariate analysis, non-pur
ged cell doses of 2-4 x 10(8) TNC/kg were significantly associated wit
h a decreased 100-day mortality compared with a dose of <2 x 10(8) TNC
/kg (P = 0.005) after adjusting for disease status and patient age at
transplant, Purged cell doses of 2-4 and >4 x 10(8) TNC/kg were not si
gnificantly different from the non-purged dose of <2 x 10(8) TNC/kg in
terms of 100-day mortality (P = 0.75 and 0.14, respectively), Engraft
ment of granulocytes and platelets was delayed in patients receiving <
2 x 10(8) TNC/kg or purged marrows compared with patients receiving no
n-purged 2-4 x 10(8) TNC/kg, Increasing cell dose in both purged and n
on-purged groups was significantly associated with improved EFS, This
study also suggests that patients in whom <2 x 10(8) TNC/kg is harvest
ed probably should not be transplanted casing autologous marrow alone.